Company / Current Liabilities
GYRE THERAPEUTICS, INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$18.3M
FY2025
5-year range
$12.2M / $20.0M
FY2021-FY2025
Trend
-6.3%
vs FY2024
Sector context
#192 of 213
Health Care
What the data says
Among 213 Health Care companies, GYRE THERAPEUTICS, INC. is in the top 10% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $5M in FY2018 to $29M in FY2019.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +0.5%.
Improved from $20M to $18M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 213This company $18.3M Sector average $1.6B
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.5%, indicating consistent growth.
- In FY2025, current liabilities decreased 6.3% year-over-year.
- Ranks #192 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.3M | -6.3% |
| FY2024 | $19.5M | -2.6% |
| FY2023 | $20.0M | +63.8% |
| FY2022 | $12.2M | -13.6% |
| FY2021 | $14.2M | -20.4% |
| FY2020 | $17.8M | -38.4% |
| FY2019 | $28.9M | +501.9% |
| FY2018 | $4.8M | -45.1% |
| FY2017 | $8.7M | -60.2% |
| FY2016 | $22.0M | -41.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026